國立高雄大學圖資館 |

Language: English

Back

Genetic influences on response to dr...

Rybakowski, Janusz K.

Genetic influences on response to drug treatment for major psychiatric disorders

Record Type:	Electronic resources : Monograph/item
Title/Author:	Genetic influences on response to drug treatment for major psychiatric disordersedited by Janusz K. Rybakowski, Alessandro Serretti.
other author:	Rybakowski, Janusz K.
Published:	Cham :Springer International Publishing :2016.
Description:	ix, 117 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	PsychiatryAlternative treatment.
Online resource:	http://dx.doi.org/10.1007/978-3-319-27040-1
ISBN:	9783319270401$q(electronic bk.)

Genetic influences on response to drug treatment for major psychiatric disorders
Genetic influences on response to drug treatment for major psychiatric disorders[electronic resource] /edited by Janusz K. Rybakowski, Alessandro Serretti. - Cham :Springer International Publishing :2016. - ix, 117 p. :ill., digital ;24 cm.

1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.

ISBN: 9783319270401$q(electronic bk.)

Standard No.: 10.1007/978-3-319-27040-1doiSubjects--Topical Terms:

741079
Psychiatry
--Alternative treatment.

LC Class. No.: RC435

Dewey Class. No.: 616.89

Genetic influences on response to drug treatment for major psychiatric disorders
LDR:02417nmm a2200313 a 4500 001 483501
003 DE-He213
005 20160819150241.0
006 m d
007 cr nn 008maaau
008 161007s2016 gw s 0 eng d
020 $a 9783319270401$q(electronic bk.)
020 $a 9783319270388$q(paper)
024 7 $a 10.1007/978-3-319-27040-1 $2 doi
035 $a 978-3-319-27040-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC435
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
082 0 4 $a 616.89 $2 23
090 $a RC435 $b .G328 2016
245 0 0 $a Genetic influences on response to drug treatment for major psychiatric disorders $h [electronic resource] / $c edited by Janusz K. Rybakowski, Alessandro Serretti.
260 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2016.
300 $a ix, 117 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.
520 $a Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.
650 0 $a Psychiatry $x Alternative treatment. $3 741079
650 0 $a Nature and nurture. $3 258755
650 0 $a Genetics. $3 189015
650 0 $a Antipsychotic drugs. $3 252256
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Psychopharmacology. $3 252258
650 2 4 $a Human Genetics. $3 273658
700 1 $a Rybakowski, Janusz K. $3 741077
700 1 $a Serretti, Alessandro. $3 741078
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-27040-1
950 $a Medicine (Springer-11650)